Immunologic Project Group 1 Part 1A
When would you use immunotherapy? View the specialists from the Northern California Melanoma Center, , answer commonly asked questions.
Immunologic Project 5
Immunologic Project 6 Part 1
Dr. Abby Abelson on Osteoporosis Dr. Abby Abelson is the Director of Education of the Center for Osteoporosis and Metabolic Bones Disease and the Education Program Director for the Department of Rheumatic and Immunologic Diseases of Cleveland Clinic Foundation. She is also the Rheumatology Editor of the Clinics Disease Management Project and a Course Director in the Cleveland Clinic Lerner College of Medicine. She has presented multiple national conferences on the subject of osteoporosis and other metabolic bone diseases including the National Osteoporosis Foundation, the American Society of Reproductive Medicine, The American College of Obstetrics and Gynecology and the American College of Physicians. She is the Chair of the Medical and Scientific Committee and on the Board of the Northeast Ohio Arthritis Foundation. In 2001 and 2005, she was awarded volunteer leadership awards by that organization. She has been named in Best Doctors in America from 1998 to 2006 and is listed in Guide to Top Doctors of the Center for the Study of Services in 1998 and 2001. For More Information: bit.ly
Immunologic Project 4 Part 2
What are some positive coping mechanisms that people can use when diagnosed with melanoma? View the specialists from the Northern California Melanoma Center, , answer commonly asked questions.
How do you determine if the melanoma has spread? View the specialists from the Northern California Melanoma Center, , answer commonly asked questions.
Immunologic Project 6 Part 3
What are the stages of melanoma? View the specialists from the Northern California Melanoma Center, , answer commonly asked questions.
What are regional lymph nodes? View the specialists from the Northern California Melanoma Center, , answer commonly asked questions.
Rockingham Memorial Hospital, Harrisonburg, VA Rockingham Memorial Hospital Harrisonburg, VA Allergies (Hayfever and Allergic Rhinitis) , Allergy & Asthma Associates of Virginia , Aquatic Therapy , Asthma and Immunologic Conditions , Asthma Including Exercise Induced Asthma , Computerized Spirometry , Food, Drug and Latex Allergy , Frequent Sinus Infections , Immune Evalua , Immune Evaluations , Immunotherapy , Inpatient , Insect Bee Sting Allergy , Military & Veteran's Services , Most Insurance Accepted , New Patients Welcome , Occupational Therapy , Outpatient , Physical Examinations , Physical Therapy , Referrals , Skin Testing , Speech Therapy , Treating Adult and Pediatric Allergy, , Treating Adult and Pediatric Allergy, Asthma and Immunologic Conditions , Treating Adult and Pediatric Allergy, Asthma and Immunologic Conditions - New Patients Welcome
Lymplex Lymph Node Cleansing Part 2 "The transformation of primitive or immature lymphocytes into T-lymphocytes and their proliferation in the lymph nodes is promoted by a thymic hormone called thymosin. Ocassionally the thymus persists and may become cancerous after puberty and and the continued secretion of thymosin and the production of abnormal T-cells may contribute to some autoimmune disorders. Conversely, lack of thymosin may also allow inadequate immunologic surveillance and thymosin has been used experimentally to stimulate T-lymphocyte proliferation to fight lymphoma and other cancers. 4. The spleen: The spleen filters the blood and reacts immunologically to blood-borne antigens. This is both a morphologic (physical) and physiologic process. In addition to large numbers of lymphocytes the spleen contains specialized vascular spaces, a meshwork of reticular cells and fibers, and a rich supply of macrophages which monitor the blood. Connective tissue forms a capsule and trabeculae which contain myofibroblasts, which are contractile. The human spleen holds relatively little blood compared to other mammals, but it has the capacity for contraction to release this blood into the circulation during anoxic stress. White pulp in the spleen contains lymphocytes and is equivalent to other lymph tissue, while red pulp contains large numbers of red blood cells that it filters and degrades. The spleen functions in both immune and hematopoietic ...
Immunological Synapse This video describes the structure and function of an immunological synapse, the zone of contact between a T cell and an antigen presenting cell. This video is from: Janeway's Immunobiology, 7th Edition Murphy, Travers, & Walport ISBN: 978-0-8153-4123-9
Immunologic Project Part 1B
The Christina and Paul Martin Foundation Benefitting Memorial Sloan-Kettering Cancer Center Presentation by Dr. Ronald DeMatteo of Memorial Sloan-Kettering Cancer Center for cancer research of immunologic therapies for the liver.
Immunologic Project 3 Part 2
What are the different phases of clinical trials? View the specialists from the Northern California Melanoma Center, , answer commonly asked questions.
Cleaning House: Detoxification & Immunologic Treatments Presented at Autism One by Dr. Phil DeMio/Angela Shoemaker
Dr. Peters Explains Potential New Treatment for Uncontrolled Asthmatics Stephen Peters, MD, Ph.D., associate director for the Center for Genomics and Personalized Medicine Research at Wake Forest University Baptist Medical Center, director of research for the section on pulmonary, critical care, allergy & immunologic diseases and lead author on a study that identified a potential new treatment for uncontrolled asthmatics, discusses the study and why the findings are important. Physician Profile: Dr. Stephen Peters www.wfubmc.edu Center for Genomics and Personalized Medicine Research www.wfubmc.edu
Immunologic Project 6 Part 2
Are the immunologic agents ever combined with chemotherapy to treat melanoma? View the specialists from the Northern California Melanoma Center, , answer commonly asked questions.
Industrial Dermatitis Prevention in a Paint Shop 1950 UK Ministry of Labour Because of the many different chemical ingredients in paints (including isocyanates, epoxies and others), painters are at risk of potentially harmful exposures of the skin. Contact dermatitis, also called eczema, is an inflammation of the skin resulting from exposure to a hazardous agent. It is the most common form of reported occupational skin disease (OSD). Epidemiological data indicate that contact dermatitis constitutes approximately 90-95% of all cases of OSD in the United States. Common symptoms of dermatitis include: itching, pain, redness, swelling, the formation of small blisters or wheals (itchy, red circles with a white centre) on the skin and dry, flaking, scaly skin that may develop cracks. Occupational dermatitis is frequently divided into two types -- first Irritant contact dermatitis, caused by direct damage to the skin following exposure to a hazardous agent, representing approximately 80% of all cases of occupational contact dermatitis. It may be caused by phototoxic responses, acute exposures to highly irritating substances (bases, oxiding/reducing agents), or chronic cumulative exposures to mild irritants (water, detergents, weak cleaning agents). The second type is Allergic contact dermatitis an inflammation of the skin caused by an immunologic reaction triggered by dermal contact to a skin allergen. For this to occur, a worker must be first sensitized to the allergen. Subsequent exposures of the skin to the allergenic agent may elicit an immunologic ...
Are there side effects from radiation therapy? View the specialists from the Northern California Melanoma Center, , answer commonly asked questions.
The Ethical Breach of Investigating GI Symptoms in Autistic Children Andrew Wakefield, MB, BS, FRCS, FRCPath is an academic gastroenterologist. He graduated in Medicine from St. Mary's Hospital (part of the University of London) in 1981, pursuing a career in gastrointestinal surgery with a particular interest in inflammatory bowel disease. He qualified as Fellow of the Royal College of Surgeons in 1985, and in 1996 was awarded a Wellcome Trust Traveling Fellowship to study small-intestine transplantation in Toronto, Canada. Discoveries made during his work in Canada led him on return to the UK to pursue the study of inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. In 1998, he and his colleagues at the Royal Free Hospital in London reported a novel inflammatory bowel disease in children with developmental disorders such as autism; the condition later became known as autistic enterocolitis. Dr. Wakefield resisted pressure to stop his research on the possible links between childhood immunizations, intestinal inflammation and autism, leaving the Royal Free School of Medicine in 2001. He is involved in many scientific research collaborations in the US and abroad, investigations centering on the immunologic, metabolic, and pathologic changes occurring in inflammatory bowel diseases such as autistic enterocolitis, links between intestinal disease and neurologic injury in children, and the possible relationship of these conditions to environmental causes, such as childhood vaccines. During the course of his work on ...
What are the side effects from the chemotherapy? View the specialists from the Northern California Melanoma Center, , answer commonly asked questions.
Flesh Grinder - Tissue Injury Caused By An Apparent Immunologic Reaction Of Host Album: Anatomy & Surgery (1997)
Immunologic Project 1 Part 2
Immunologic Project 4 Part 1
Industrial Dermatitis 1950 UK Ministry of Labour Contact dermatitis, also called eczema, is an inflammation of the skin resulting from exposure to a hazardous agent. It is the most common form of reported occupational skin disease (OSD). Epidemiological data indicate that contact dermatitis constitutes approximately 90-95% of all cases of OSD in the United States. Common symptoms of dermatitis include: itching, pain, redness, swelling, the formation of small blisters or wheals (itchy, red circles with a white centre) on the skin and dry, flaking, scaly skin that may develop cracks. Occupational dermatitis is frequently divided into two types -- first Irritant contact dermatitis, caused by direct damage to the skin following exposure to a hazardous agent, representing approximately 80% of all cases of occupational contact dermatitis. It may be caused by phototoxic responses, acute exposures to highly irritating substances (bases, oxiding/reducing agents), or chronic cumulative exposures to mild irritants (water, detergents, weak cleaning agents). The second type is Allergic contact dermatitis an inflammation of the skin caused by an immunologic reaction triggered by dermal contact to a skin allergen. For this to occur, a worker must be first sensitized to the allergen. Subsequent exposures of the skin to the allergenic agent may elicit an immunologic reaction resulting in inflammation of the skin. The reaction is not confined to the site of contact and may result in systemic responses. This may be caused by industrial ...
Skin Cancer Squamous Cell Carcinoma Appearance Dr. Shane Chapman, MD discusses Skin Cancer Squamous Cell Carcinoma Appearance. See more at PLEASE RATE AND COMMENT!!! SCCs arising from actinic keratoses may have a thick, adherent scale. The tumor is soft and freely movable and may have a red, inflamed base. These lesions are most frequently observed on the bald scalp, forehead and backs of the hands. Cutaneous horns may begin as actinic keratoses and degenerate into SCC. SCCs originating on the lip or from apparently normal skin are aggressive and metastasize to the regional lymph nodes and beyond. Those SCCs beginning in actinically damaged skin, but not from actinic keratoses, appear as firm, movable, elevated masses with a sharply defined border and little surface scale. The potential for SCCs to metastasize is related to the size, location, degree of differentiation, histologic evidence of perineural involvement, immunologic status and depth of invasion. SCCs that arise in actinically damaged skin were previously thought to have a minimal potential for metastasis; however, such lesions may be aggressive. SCC first metastasizes to regional lymph nodes in the majority of cases.
Immunologic Project 2
Therapy Helps Some with Peanut Allergies to Tolerate Peanuts A carefully administered daily dose of peanuts has been so successful as a therapy for peanut allergies that a select group of children is now off treatment and eating peanuts daily, report doctors at Duke University Medical Center and Arkansas Children's Hospital. "It appears these children have lost their allergies," says Wesley Burks, MD, Chief of the Division of Pediatric Allergy and Immunology at Duke. "This gives other parents and children hope that we'll soon have a safe, effective treatment that will halt allergies to certain foods." Long-term tolerance in children with peanut allergies was documented for the first time by the presence of key immunologic changes, according to researchers at Duke and Arkansas Children's Hospital who presented their findings at the American Academy of Asthma and Immunology meeting in Washington, DC on March 15, 2009. Tests of several immunologic indicators suggest the body builds tolerance quickly. "At the start of the study, these participants couldn't tolerate one-sixth of a peanut," Burks said. "Six months into it, they were ingesting 13 to 15 peanuts before they had a reaction." About four million Americans have food allergies, and allergies to tree nuts, such as peanuts, are the most common. Life-threatening reactions can occur from exposure to even a trace amount of peanuts, and nearly half of the 150 deaths attributed to food allergies each year are caused by peanut allergies. Duke and Arkansas Children's Hospital began ...
Conquering Cancer: An Immunologic Model of HOV-Induced Oncogenesis For the full video, click here: Centricity Series website: Molecular Medicine website: Feinstein Institute website: North Shore-LIJ website:
Progencell -English General information about stem cell treatments of stem cell therapies obtained from Bone Marrow at Progencell for degenerative diseases.
Cancer Immunotherapy Treatment Quantum Immunologics is in the process of developing an immunologic treatment for breast cancer that may have positive effects on other types of cancer as well. Phase I and II clinical trials are currently under way in Mobile Alabama. The current trial has a patient base of 27 women with stage IV breast cancer. Go to to help fund this process and find out more.
10.402GS Laparoscopic Partial Splenectomy for a Splenic Cyst TITLE: Laparoscopic Partial Splenectomy for a Splenic Cyst Background: The spleen's role in immunologic function along with a risk of overwhelming postsplenectomy infection has led to an increased popularity of splenic preserving surgery. This is especially true for benign pathologies of the spleen. We herein show a video of laparoscopic partial splenectomy for a 6-cm x 5-cm splenic cyst. Method: The patient is a 37-year-old female who was referred to our clinic for a 6-cm x 5-cm splenic cyst. The cyst was first noted on an abdominal-pelvic CT scan back in 2004. A repeat CT scan in 2009 once again showed a cyst with calcified rim that has not changed in size since 2004. A splenic cyst greater than 5cm in size has an increased risk of spontaneous rupture during pregnancy, which ultimately leads to poor maternal and fetal outcome. Because the patient wished to conceive, she was consented for laparoscopic partial splenectomy. This will allow the removal of a likely benign cyst while preserving splenic function. The surgery consists of patient positioning, trocar placement, mobilization of the spleen from its embryologic peritoneal attachments, dissection, and transaction of the arterial and venous branches to the respective pole of the spleen, parenchyma division, cauterizing, and obtaining hemostasis at the transected edge, and retrieval of the specimen. The operation took 110 minutes. Results: The patient was hospitalized for 2 days and was discharged without complications ...
Guillain-Barre syndrome, stem cells therapy (english subtitles) Stem cell treatment for immunologic syndrome (Spanish with english subtitles, 3:16 min)
Immunologic Project 3 Part 1